Versor Investments LP Makes New $705,000 Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Versor Investments LP acquired a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 5,300 shares of the company's stock, valued at approximately $705,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Ellsworth Advisors LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $598,000. Quadrature Capital Ltd acquired a new position in shares of Addus HomeCare in the 1st quarter valued at $1,557,000. Lord Abbett & CO. LLC acquired a new position in shares of Addus HomeCare in the 1st quarter valued at $8,274,000. SG Americas Securities LLC acquired a new position in shares of Addus HomeCare in the 2nd quarter valued at $842,000. Finally, Quantbot Technologies LP acquired a new position in shares of Addus HomeCare in the 1st quarter valued at $715,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Royal Bank of Canada decreased their price target on Addus HomeCare from $141.00 to $136.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 6th. Stephens upped their price target on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a report on Thursday, August 8th. Macquarie reiterated an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Finally, KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Addus HomeCare currently has an average rating of "Moderate Buy" and an average price target of $131.63.

Insiders Place Their Bets

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the company's stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock valued at $3,050,082 in the last ninety days. Insiders own 4.60% of the company's stock.

Addus HomeCare Stock Down 1.1 %

NASDAQ ADUS traded down $1.33 during mid-day trading on Wednesday, hitting $124.82. The stock had a trading volume of 30,961 shares, compared to its average volume of 131,424. Addus HomeCare Co. has a 52-week low of $83.46 and a 52-week high of $136.12. The company has a market cap of $2.26 billion, a price-to-earnings ratio of 28.87, a P/E/G ratio of 2.24 and a beta of 1.04. The company has a 50 day simple moving average of $129.42 and a 200 day simple moving average of $122.06.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's quarterly revenue was up 7.1% on a year-over-year basis. During the same period last year, the business posted $1.03 EPS. As a group, equities analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.